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Background
Highly active antiretroviral therapy (HAART) has now 
been available for more than 10 years, profoundly chang-
ing the way we think about HIV, turning victims into 
survivors. Reliably robust results have been documented 
repeatedly in high- and low-income settings, with adults 
and with children [1,2]. Despite its long-standing record 
of proven eﬃ   cacy, this treatment remains inaccessible to 
most children born with HIV in many low- and middle-
income countries today.
In the ﬁ   ve countries with the highest adult HIV 
prevalence worldwide, HIV is the single leading cause of 
under-ﬁ  ve mortality, responsible for 41% to 56% of deaths 
[3]. One thousand children were born with HIV every 
day in 2007, due in part to the fact that only about 45% of 
all HIV-positive women worldwide have access to 
preven  tion of mother to child transmission (PMTCT) 
programmes [4]. Less than half of the children born with 
HIV in Africa are expected to survive until their second 
birthday [5].
With early diagnosis and treatment, however, their 
outlook improves substantially. For example, the Children 
with HIV Early Antiretroviral Th  erapy trial recently 
demonstrated a 76% reduction in mortality for children 
born with HIV when HAART was started within the ﬁ  rst 
12 weeks of life [6]. Among infected children of all ages, 
HAART initiation can decrease hospital admissions, 
incidence of pneumonia, and diarrhoea, can bring about 
“signiﬁ   cant immunological reconstitution” and, in the 
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survival after one year of therapy of between 84% and 
97% [1].
Children (infected and uninfected) also receive sub-
stantial indirect beneﬁ  ts when their parents are treated: 
decreases in malaria, diarrhoea, hospitalizations and 
mortality have been seen, as well as improvements in 
child nutritional status and school enrolment, and 
decreases in child labour [7-9]. In the context of HIV, 
family members have been shown to signiﬁ  cantly impact 
the mental health, access to care, adherence and 
treatment outcomes of other family members [7,9-13]. 
However, only 38% of children and 43% of adults 
requiring antiretroviral therapy (ART) are currently able 
to access treatment [4]. Family-centred care models have 
emerged as a way to meet the clear and present need to 
test and treat more HIV-positive children and caregivers 
in a way that is mindful of intimate and dynamic family 
relationships (see Figure 1).
Th   e concept of “family-centred care” was ﬁ  rst formally 
deﬁ   ned in 1982 by the Association for the Care of 
Children’s Health in response to a growing desire for a 
new approach to care for children with special health 
needs. It was based on a bio-psychosocial systems 
approach: the primary focus of health care is the client in 
the context of their family [14]. While the family was 
originally assumed to include healthy adults as caregivers 
for the child, deﬁ  nitions have evolved to meet the reality 
created through the vertical transmission of HIV. HIV 
family-centred care is now described simply as pro-
grammes where “adult and paediatric services are 
provided together in a single setting” [15].
While that is the working deﬁ  nition used in this paper, 
it is important to acknowledge that more ambitious 
deﬁ   nitions exist, which broaden the mandate of care 
providers beyond basic HIV services. For example, 
another deﬁ  nition is: “A comprehensive, coordinated care 
approach that addresses the needs of both adults and 
children in a family and attempts to meet their health and 
social care needs, either directly or indirectly through 
strategic partnerships and/or linkages and referrals with 
other service providers” [16].
Th  ere is currently no consensus as to what meeting 
“health and social care needs” means, as evidenced by the 
diversity of programmes reviewed in this paper. Th  ese 
myriad approaches illustrate the diﬃ   culty  in  drawing 
general conclusions about the eﬃ     cacy of any given 
intervention, but also point to a broad global interest in 
exploring this care delivery model.
Objectives
Th   e goal of this paper is to review existing literature on 
family-care models used to treat children and caregivers 
living with HIV. Th   e features of the HIV/AIDS 
family-centred care programmes, as well as paediatric 
cohort characteristics, are described, including demo-
graphics, treatment outcomes, adherence and retention. 
Lessons learned and recommendations for future inter-
ventions and research will be identiﬁ  ed. Although the 
health of families is a complex and interrelated system, 
the focus will be mainly on the impact of the family-care 
model on the health of children living with HIV.
Methods
Th  e current study is a systematic review of English-
language  literature on family-centred HIV care pro-
grammes. Due to the low number of peer-reviewed 
publications on this topic, unpublished conference 
abstracts were also included. All relevant publication 
dating until August 2009 were identiﬁ  ed by searching the 
PubMed database. Th   e International AIDS Society (IAS) 
abstract search was used to identify abstracts, posters 
Figure 1. HIV/AIDS from a family perspective.
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5th IAS Conferences on HIV Pathogenesis and Treatment 
(2001, 2003, 2005, 2007, 2009), and XIV to XVII Inter-
national AIDS Conferences (2002, 2004, 2006, 2008).
Th  e following search terms were used: (“famil*”) + 
(“HIV” OR “AIDS” OR “HAART” OR “antiretroviral*”); 
also (“MTCT plus” OR “PMTCT plus”). Review of the 
citations within the articles found yielded additional 
articles. Final inclusion criteria included: (1) provision of 
treatment for HIV-positive adults and children in a single 
setting; and (2) a description of at least one of our 
measures of interest (services provided, cohort epidemio-
logy, service uptake, testing, clinical/lab outcomes, 
adherence, retention, psychosocial support). Papers that 
did not address the treatment of HIV-positive children 
(such as publications on prevention of mother to child 
transmission or the follow up of HIV-exposed infants 
alone) were not included.
Data analysis primarily consisted of calculating ranges 
and measures of central tendency, when possible. Formal 
meta-analytic techniques could not be applied for a 
comparative analysis because of methodological and data 
collection discrepancies across studies.
Results
Twenty-ﬁ   ve publications and abstracts met inclusion 
criteria (cited throughout). Papers were published between 
1997 and 2009, describing cohorts primarily in Africa, 
the US and the UK. Publications that were part of the 
Mother to Child Transmission Plus Initiative (MTCT-Plus) 
were considered separately if they were determined to 
describe discrete patient groups across unique time 
periods [17], while reports containing aggregate data on 
the same patient populations were not considered unique 
cohorts [18,19]. Similarly, results from two reports by 
Sendzik [20,21] detailing the Program for AIDS Treat-
ment and Health (PATH) in Brooklyn, New York, USA, 
were combined.
Twenty-two separate cohorts were identiﬁ  ed. All docu-
mented programme characteristics, and eight provided 
paediatric outcomes data [22-29]. See Additional File 1 
and Table 1 for additional cohort references.
Setting
Nineteen reports detailed the physical location where the 
patients were treated. A signiﬁ  cant majority (n=11) were 
located in ambulatory HIV clinics aﬃ   liated with various 
hospitals: community, teaching, public, and paediatric. 
Gibb et al report that this decision “had the advantage … 
of being non-stigmatising (other paediatric outpatient 
clinics are held in parallel)” [30]. At Red Cross Children’s 
Hospital in South Africa, the programme includes an 
inpatient consultation service, created to optimize the 
care of patients in the early stages of therapy who require 
hospitalization [22].
Five family-care programmes were based at govern-
ment primary health centres. Th   ese locations were often 
conveniently located in settlements where families lived, 
and at the time of enrolment, were already oﬀ  ering a full 
range of primary care services for adults and children, 
Table 1. Paediatric cohort characteristics and outcomes
Author/  # children   Age at  Duration of  CD4 at      Loss to
Date  on HAART  initiation  follow up  initiation  Adherence  Survival  Follow-Up
Abrams   144    Median 19 months       
2005 [18]      (Range 2 months – 
     12  years)       
Van Griensven   332  Median 7.2 years  Median 2.0 years  Median 14%   49%: >95% adherence  98% survival at 12 months  12 children
2008 [28]    (IQR 4.5-10.4)  (IQR 1.2-2.6)  (IQR 9-18%)  46%: >80% adherence  8 deaths (2.6% mortality)  (3.8%)
Eley   80  Median 1.25 years      “Most” : >85% adherence  7 deaths (8.8% mortality)  4 children 
2004 [22]    (Range .003-12.0)          (5%)
Habibu   52        >95% adherence    0 children
2006 [23]*             
Lusiama   393  Median 7.5 (years)  Median 21.9 months  Median 12%     30 deaths (8% mortality)  44 children
2004 [24]*    (IQR 4.3-10.5)  (IQR 7.5-25.9)  (IQR 7-18%)      (9%)
Midturi   56  Mean 39.6 months  Mean 14.7 months    77.8% adherence  1.8% mortality  1.8%
2008 [25]*   
Reddi   151  Median 5.7 years  Median 8 months  Median 7.4%   59.6%:  no missed doses  90.9% survival at 12 months  0 children
2007 [26]    (Range 0.3-15.4)  (IQR 3.5-13.5)  (IQR 2.1-13.7%)  29.8%:  >95% adherence  13 deaths (8.6% mortality) 
Tonwe-Gold   43    Median 12 months      2 deaths (4.9% mortality)  0 children
2009 [27]      (IQR 5.0-15.0)     
Van Winghem   657  Median 5.5 years  Median 1.36 years      95.3% survival at 12 months  67 children
2008 [29]    (IQR 3.2-8.7)  (IQR 0.6-2.2)      7 deaths (6.7% mortality)  (10.2%)
* Indicates that this refers to a conference abstract, rather than a published journal article
Note: An empty table cell indicates none of that type of data were available in that publication
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were tested at antenatal clinics and referred to these 
centres for care often failed to present for enrolment: in 
Kinshasa, Democratic Republic of the Congo, for example, 
only 27% of eligible women presented with their new-
borns [31].
Four family-care sites were located at antenatal or 
PMTCT clinics: three were hospital aﬃ   liated and one 
was community based. Although this facilitated maternal 
follow up, Tonwe-Gold theorized that the location “may 
have prevented a larger number of men from choosing to 
access the services provided” [27].
Staffi   ng
Most programmes were staﬀ  ed by a core multi  disci  plinary 
team, including doctors, nurses, social workers and/or 
counsellors. Some included gynaeco  lo  gists, child life 
specialists, and/or nutritionists. However, to navigate the 
challenges of trained health care worker shortages, several 
programmes took more innovative approaches to staﬃ   ng.
Programmes that were part of MTCT-Plus, supported 
by the International Center for AIDS Care and Treat-
ment, assembled and trained multidisciplinary teams at 
each site. Personnel were trained using a speciﬁ  c MTCT-
Plus curriculum focusing on the team as a whole [17]. In 
a separate intervention in Nigeria, Habibu et al trained 
paediatricians to manage both children and adults for 
HIV-related conditions and prescribe ART, instead of 
training adult physicians to treat children. However, they 
caution, “Staﬀ    motivation can be impacted by the 
complexity of managing both children and adults and the 
multiple needs of the family” [23].
Project sites in Rwanda and Kenya implemented task-
shifting measures to varying degrees. In Kigali, Doctors 
Without Borders-supported clinics piloted “health 
center/nurse-based care”. Nurses were trained to initiate 
and change antiretroviral (ARV) treatment, and perform 
routine follow up. Th  ey observed a gradual decrease in 
the need of physician time from one full-time physician 
per 1500 patients to one per 3000 patients as the 
programme matured. To avoid overloading the nurses, 
other tasks were taken over by “new or reinforced cadres 
in the health centers”: receptionists, community support 
groups, and lab staﬀ   [28].
In Kenya, “rapid turnover of trained medical staﬀ  ” was 
identiﬁ   ed as a major challenge. Van Winghem et al 
propose training selected HIV-positive patients as peer 
educators and counsellors to take over those respon-
sibilities from paid staﬀ   , as the volunteers “would be 
more likely to remain long-term with the program” [29].
Programme components
Programmes vary widely in terms of services provided 
(see Additional File 1). Some oﬀ  er only comprehensive 
HIV care to children and adults, and others provide 
supplementary services, such as primary care for all 
family members (HIV positive and HIV negative), TB 
screening and isoniazid prophylaxis, reproductive health 
services, nutritional supplementation, play therapy for 
children, and terminal care services. Locations of the 
programmes determined to some extent which services 
were oﬀ   ered: antenatal clinic-based programmes were 
better equipped to oﬀ   er PMTCT services [32], and 
paediatric hospital-based programmes were well 
positioned to mobilize inpatient consult teams [22].
Enrolment
Enrolment points varied widely, and included: antenatal 
clinics, PMTCT programmes, adult/adolescent HIV 
clinics, inpatient adult and paediatric wards, maternal 
and child health clinics, and subsequent use of “index 
patients” within the recruited cohort to identify HIV-
positive family members. Many sites relied on a 
combination of the above techniques. Th  e enrolment 
method often inﬂ  uenced the inclusion or exclusion or 
various demographic groups within the treatment cohort.
1. MTCT-Plus
A commonly used and well-documented strategy is 
MTCT-plus, a model of care that was developed from the 
MTCT-Plus Initiative [19]. Pregnant women are tested at 
antenatal or PMTCT clinics and, if HIV positive, referred 
to the family-care programme; they become the “index 
women”. Upon enrolment, they are encouraged to bring 
children and male partners for testing and, if necessary, 
treatment and care. Although these programmes are 
extremely eﬀ   ective at recruiting HIV-positive women 
and supporting prevention of mother to child trans-
mission, they have documented little success in recruiting 
HIV-positive children into care.
Figure 2 describes three MTCT-Plus cohorts: Tonwe-
Gold in Cote d’Ivoire, Yalala in Kinshasa, Democratic 
Republic of Congo, and El-Sadr. , which describes a 
composite cohort from 12 programmes in nine countries 
[17,27,31]. Despite a combined total of 1760 index 
women reported by the three authors, together they 
document only 74 children on HAART.
Th  e uptake of testing for previously born children of 
the index women is particularly low. Various theories are 
oﬀ   ered, including “the possibility that many of the 
children lived away from the mother’s household with 
other relatives in distant communities”. Th  is may be 
exacerbated by low rates of disclosure to a male partner, 
as revealing a child to be HIV positive might by extension 
reveal the mother’s status. Figure 2b describes the same 
three cohorts in terms of partner enrolment. Again, 
Tonwe-Gold’s study is the only one to document how 
many living male partners are reported (n=568) [27].
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Other cohorts use adults (male and female) in their 
existing HAART cohorts as index patients to recruit 
other family members. Ninety percent of the children in 
a large Rwandan cohort were children of adult HIV-
positive patients (299 out of 332) [28]. Some programmes 
used incentives to encourage parents to enrol children: 
Sinikithemba Clinic in Durban, South Africa, oﬀ  ered free 
paediatric care to children whose parents were enrolled, 
and referred family members were prioritized for treat-
ment [26]. Adult patients in Kenya were allowed to enrol 
in care at an earlier WHO clinical stage if they had a child 
in care [29].
Some cohorts have seen increased paediatric referrals 
since implementing family-centred care (the proportion 
of patients at Family AIDS Care and Education Services 
in Kenya who are children has doubled from 5% to 10%), 
but others are struggling to recruit paediatric patients 
[33]. At ﬁ  ve health facilities in South Africa, HIV-positive 
patients were given referral cards to pass along to family 
members. Despite the fact that 33% of these adults 
reported not knowing their children’s HIV status, the 
referred population was primarily adult (mean age 34 
years) [34].
Only two programmes described interventions 
speciﬁ   cally aimed at increasing paediatric enrolment: 
Figure 2. (a) MTCT-Plus paediatric cohorts. (b) MTCT-Plus male partner cohorts.
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waiting rooms encouraging parents in care to bring their 
children for testing [34]; and “in-depth counseling 
sessions … with the caregivers to discuss testing of 
children in detail” [28]. Outcome data on these interven-
tions are not currently available.
3. Paediatric index patients
Some projects prioritize the recruitment of children, and 
rely on them to precipitate the diagnosis of adult family 
members. At Family Clinic for HIV at Tygerberg 
Academic Hospital in South Africa, the majority of 
infants and children living with HIV were identiﬁ  ed 
through clinical suspicion based on hospitalization with 
“intercurrent disease or opportunistic infection”. Parents 
were identiﬁ  ed both through their children and with the 
input of the adult identiﬁ   cation document service. 
However, the authors report “inadequate utilization by 
the parents, especially the fathers”; only 18% of potential 
parents attended the clinic [35].
In South London, UK, children were referred from a 
variety of sources, including paediatricians from district 
hospitals, social workers and general practitioners. Th  e 
majority of parents had not been tested at the time their 
children ﬁ  rst attended the HIV clinic, but in the ﬁ  ve-year 
description of the programme, only 17% chose to remain 
untested. Again, the majority of adult patients who 
registered in care with their children were mothers (76%).
Paediatric characteristics and outcomes
Paediatric baseline characteristics and outcomes were 
available for nine programmes. Very little data was 
available on clinical, immunological or virological out-
comes. However, most studies documented cohort size, 
follow-up time, age of cohort, and rates of adherence, 
retention in care and mortality.
Cohorts contained between 43 and 657 children, and 
approximately one-third served <100. Median follow-up 
time after HAART initiation was recorded for eight 
cohorts, and ranged from 6.7 months to more than two 
years. Eight cohorts report average patient age at HAART 
initiation: half had a median age >5 years old, and half 
<5  years old, with two <2 years. CD4 percentage at 
initiation was reported by only three studies, and ranged 
from 7.4% to 14%.
Adherence data was available for six cohorts, and was 
assessed by methods ranging from patient self-report to 
pharmacy reﬁ  ll. Th   e lowest adherence rate achieved was 
77.8%, and four cohorts reported >95% adherence for the 
majority of their patients. Families on ART in Malawi, 
who are supervised for adherence by treatment helpers 
selected among HIV-positive clients, achieved an adher-
ence rate of 99.7% [36]. Byakika-Tusiime et al note “near 
perfect adherence to ART” in both mothers and children 
when treatment was provided to all eligible HIV-positive 
family members [37].
In a particularly striking case study of a family with six 
family members living with HIV, all of whom were 
started together on HAART in rural Kenya, “excellent 
outcomes” were achieved despite a family total of 49 
individual pill or syrup administrations daily [38]. Th  ese 
assessments, though imprecise, compare favourably to 
those of similar cohorts [2].
Excellent attendance at scheduled clinic visits was 
documented in several cohorts. Th  e Global HIV/AIDS 
Initiative Nigeria Project in Kano, Nigeria, reports that in 
nearly a year of managing 202 children and 90 parents, 
only two clients missed scheduled clinic appointments 
[23]. In fact, family-care patients seem to be more likely 
to attend scheduled visits: in 2007, adults in the Family 
Program at PATH (the HIV service of Brooklyn Hospital, 
New York) kept 74% of their medical visits, compared to 
44% for PATH patients overall [20,21].
Loss-to-follow-up (LTF) rates were low in the majority 
of studies: 10 report <11% LTF, including Ida et al, who 
demonstrated >90% retention during a seven-year obser-
vation period. Th   ree cohorts report zero patients lost to 
follow up. One study, by Niekerk et al, reports 52% LTF, 
although this should be interpreted in light of the fact 
that this was predominantly a pre-HAART era report, 
and only 22% of the children were receiving HAART 
through various clinical trials [35].
Th  e probability of survival one year after HAART 
initiation was 90.9% to 98% [26,28,29], and overall mor-
tality ranged from 1.8% to 8.8% [22,24,25,27]. Several 
studies highlighted a particularly vulnerable period shortly 
after the initiation of HAART: all of the deaths (n=7) 
reported by Eley took place within six weeks of HAART 
initiation, 70% of the deaths reported by Lusiama within 
three months, and all of the deaths (n=13) reported by 
Reddi within ﬁ   ve months [26,36,39]. Th  is ﬁ  nding  is 
consistent with the experience of other paediatric HIV 
treatment programmes in resource-limited settings [2].
Th   ree articles identiﬁ  ed predictors of mortality and LTF 
in family care cohorts. Reddi et al report that HIV-positive 
caregivers showed a protective eﬀ   ect against mortality 
when compared with caregivers who were untested or HIV 
negative [26]. Lusiama et al compared children in the family 
care cohort both with and without participating family 
members, and found that the rate of deactivation/death was 
higher among children without a family member partici-
pating in the programme [24]. A three-year retrospective 
case-control-matched study of children on ART enrolled at 
the Baylor Center of Excellence family clinic in Lilongwe, 
Malawi, and children receiving routine paediatric ART 
revealed better outcomes in family clinic cases compared 
with controls regarding retention in care, death, LTF, 
stopped ART, and transfer to other ART sites [25].
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Limitations
Due to the emerging and evolving nature of the family-
centred care model, no ﬁ  xed deﬁ  nition exists to facilitate 
the classiﬁ   cation of programmes as family-centred or 
not. Consequently, studies included in this review were 
chosen on the basis of self-identiﬁ  cation. Additionally, no 
consistency across studies exists with regard to 
programme components or data collection, precluding 
rigourous comparison and evaluation. Given the low 
number of peer-reviewed publications on this topic, a 
signiﬁ   cant number of conference abstracts were also 
included in order to provide a more complete picture of 
the work being done “on the ground”.
Challenges to care and management – lessons learned
Preliminary data from family-centred care sites suggest 
that this model can be an eﬀ  ective tool for recruiting 
HIV-positive women, preventing mother to child 
transmission, increasing paediatric and adult referrals, 
supporting patient adherence and clinic attendance, and 
improving paediatric clinical outcomes. Th  e data also 
describe a number of challenges encountered by pro-
gram  mes in their eﬀ  orts to provide comprehensive health 
care for the whole family.
Th  e majority of programmes described here reported 
challenges in recruiting one or more types of family 
members: females, males and children. Th   ose with robust 
paediatric cohorts often struggled to recruit parents, and 
those with large numbers of HIV-positive mothers in care 
had great diﬃ   culty recruiting male partners and children. 
Fathers were the least likely to access care in all scenarios: 
as Tonwe-Gold wryly observed, involving males in family 
services like MTCT-Plus “is known to be very taxing” [27].
Failure of HIV-positive females to disclose their status 
to male partners has been well documented: fear of 
accusations of inﬁ   delity, abandonment, discrimination, 
loss of economic support, and violence are often cited as 
primary reasons. Th  ese fears are not groundless. A 
review of 17 studies found that between 3.5% and 14.6% 
of women reported experiencing a violent reaction from 
a partner following disclosure; other negative outcomes 
included separation from partner, abuse by in-laws, or 
being forced to move away from home [40]. Low levels of 
disclosure may negatively aﬀ  ect not only the likelihood 
that fathers will enrol in care, but also that mothers will 
seek testing and treatment for their children.
Several studies described the failure of the “trickle-
down” method of paediatric enrolment. Th  e  assumption 
that adults in care will refer their children for testing and 
treatment is not borne out by the clinical evidence and 
requires serious reconsideration.
Children living with extended family are made 
particularly vulnerable to exclusion from treatment. By 
2010, it is estimated that 20 million children in sub-
Saharan Africa – 12% of all children in the region – will 
have been orphaned by AIDS [41]. In Namibia, Tanzania 
and Zimbabwe, the United Nations Children’s Fund 
(UNICEF) reports that grandmothers are responsible for 
the care of 40% to 60% of orphaned children. According 
to Mudzingwa and Reddi, non-parental caregivers are 
signiﬁ  cantly less likely to know their own status, and thus 
to be in care for HIV [26,42]. Th  erefore, family-care 
models that depend solely on adult index patients are 
likely to miss the substantial proportion of HIV-positive 
children who live with non-biological caregivers.
DeGennaro suggests that family-centred programmes 
are able to “locate infections at earlier disease stages”, and 
there is some tentative data to support their success in 
this endeavour [43]. Although age of enrolment is not an 
ideal surrogate for disease stage, it is the best indicator 
available, and there is likely to be some overlap between 
the two. Half of the family-centred HAART cohorts had a 
median paediatric cohort age of <5 years, whereas a 
review of paediatric antiretroviral cohorts in sub-Saharan 
Africa showed that only about ¼ of their cohorts had a 
median age of <5 years [1].
MTCT-Plus programmes have documented particu-
larly strong results: in Uganda, less than 1% of HIV-
exposed infants in the programme died before testing 
[32]. Abrams et al reported that in 2004, a remarkable 
37% of the paediatric cohort at all MTCT-Plus sites 
worldwide was less than one year of age [19]. However, it 
is necessary to ﬁ  nd ways to replicate this success with 
infants who have a greater risk of infection, such as those 
whose mothers did not participate in MTCT.
Th  e frequency of paediatric deaths at the onset of 
HAART, documented by Reddi, Eley and Lusiama, 
reﬂ  ects a much larger trend across paediatric HIV treat-
ment models. Sutcliﬀ   e, in a comprehensive review of 
paediatric HIV cohorts in sub-Saharan Africa, reports 
that “most deaths occurred within 6 months of treatment, 
with several studies reporting a mean or median time to 
death of 57-182 days” [2]. Identifying high-risk patients at 
the onset of treatment is an urgent necessity, especially in 
family-centred care settings where family members 
receiving treatment at the same site are well-positioned 
to serve as allies in the care of the high-risk child.
Finally, many of the programmes reviewed here have 
structural diﬃ   culties that limit their ability to provide 
comprehensive paediatric and adult care. A survey of 
non-governmental organizations by DeGennaro reveals 
“lack of healthcare workers trained in pediatrics” as the 
most common reason for the failure to provide treatment 
to children with HIV [44]. Th  is sentiment is echoed in 
surveys of barriers to paediatric care in Zambia [45], 
South Africa [46] and district hospitals throughout Africa 
[47]. In Malawi, Lesotho, Swaziland and Botswana, per 
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per 100,000 children [48].
Even trained staﬀ   can be overwhelmed by the increased 
volume of patients, or may view the attention to 
paediatric care in addition to adult care as an unnecessary 
burden. Finally, the simple logistics of ﬁ  nding space for 
additional programming at already overcrowded clinics 
may be diﬃ     cult. In a community-based government 
health clinic in Kenya, “Th  ere was limited physical 
capacity of the clinics to provide child-speciﬁ  c activities 
and rooms” [29].
Recommendations and interventions – a way forward
1. Goal 1: Expand patient recruitment eff  orts
New methods of patient recruitment must be incor  por-
ated into family-centred care provision if more children 
are to be diagnosed, and diagnosed at earlier stages of 
illness. A variety of opportunities present themselves, 
including: immunizations, postpartum care, sick/well 
baby clinics, and inpatient paediatric wards. Th  ese sites 
would allow identiﬁ   cation of both symptomatic and 
asymp  tomatic children, and include children with non-
biological caregivers who might otherwise be missed in a 
parent-centred care and recruitment model. Studies 
addressing the acceptability of such interventions have 
found that routine HIV counselling and testing could be 
successfully incorporated into immunization clinics, 
paediatric inpatient wards, malnutrition treatment pro-
gram  mes and paediatric emergency departments with 
high parental acceptance rates [49-52].
It is also important to develop thoughtful, context-
speciﬁ   c interventions both to support adult HAART 
patients’ referral of their partners and children, and to 
en  courage the caregivers of paediatric HAART patients 
to be tested themselves. Th  ese eﬀ  orts need to take into 
account the very real danger faced by many women 
worldwide when disclosing their status to a partner. 
Counsellors should be trained to identify women most at 
risk for negative outcomes, and provide additional 
support, including referral to domestic violence services 
when necessary [40].
Interventions that might support the positive 
participation of males in HIV testing and treatment 
include utilizing male health care workers and 
counsellors, and establishing “fathers’ clinics” or similar 
male-centred activities as an opportunity for education 
and peer support [53].
2. Goal 2: Pay special attention to children during the fi  rst six 
months of HAART
While not speciﬁ  c to family-centred care, the unaccep-
tably high risk of mortality for paediatric patients during 
the ﬁ   rst six to 12 months of HAART needs to be 
addressed by all paediatric providers.
Integration of family-centred services may be useful in 
mitigating some of these risks. Incorporating therapeutic 
and supplementary feeding with HIV treatment pro-
gram  mes could support patients who are malnourished, 
and combining HIV care with TB screening and treat-
ment might result in a lower TB incidence at baseline. 
Reddi et al recommend children identiﬁ  ed as high risk at 
baseline be referred to paediatric inpatient wards or a 
local palliative (step-down) care centre for HAART 
initiation [26]. Other simple measures could include 
scheduling more frequent follow-up appointments after 
initiation, or treatment counsellor home visits. With the 
appropriate support, adult family members in care at the 
same treatment site could provide invaluable support and 
expertise during this treacherous time.
3. Goal 3: Develop comprehensive services
At this point, it is diﬃ   cult to identify which components 
of a family-centred care programme might be the most 
crucial and eﬃ   cacious. Tolle, in advocating for a package 
of primary health services for comprehensive family-
centred HIV/AIDS care, acknowledges that “implement-
ing (packages) will require substantial and long-term 
invest  ments in infrastructure and human resources”. 
How  ever, in the short term, services packages may 
present “a framework around which a programme may 
construct its own particular model of care, providing 
those services for which it is able while ﬁ  nding a reference 
point for the development of its future capacities” [15].
Additionally, establishing a consensus as to which 
interventions deﬁ   ne family-centred care would allow 
researchers not only to independently validate discrete 
interventions, but also to compare broadly the eﬀ  ects of a 
standardized set of interventions comprising “family-
centred care” versus more traditional segmented adult 
and paediatric care.
For these reasons, we suggest here, in Table 2, a “wish 
list” of services, compiled from the recommendations of 
Tolle, Richter, DeGennaro, and DeBaets [15,43,47,54].
Conclusions
Family-centred care can be implemented in developed and 
developing world settings. Although data is currently 
limited, and additional research is urgently required, 
family-centred care produces good outcomes in terms of 
service uptake, clinical outcomes, adherence and retention.
Important considerations for future programming 
include building personnel and infrastructural capacity, 
innovating methods for testing hard-to-reach popula-
tions within the family, identifying and implementing 
specialized services for high-risk populations early in 
treatment, and providing a full range of comprehensive 
services for all family members. Additionally, more 
consis  tent documentation of programme experiences, 
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would promote the development of understanding of 
how, and when, family-centred care is most eﬀ  ective.
Additional File
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SCL undertook the study concept and design, and analysis and interpretation 
of data. BTM, JFF and TPF were responsible for critical revision of the 
manuscript for important intellectual content. All authors have read the fi  nal 
manuscript and approved it for publication.
Acknowledgements
This study was supported by a grant from the Coalition for Children Aff  ected 
by AIDS. The authors gratefully acknowledge the technical writing assistance 
of Philip McIntosh and Julia de Kadt.
Published: 23 June 2010
References
1.  Akileswaran C, Lurie MN, Flanigan TP, Mayer KH: Lessons learned from use of 
highly active antiretroviral therapy in Africa. Clin Infect Dis 2005, 
41(3):376-385.
2. Sutcliff  e CG, van Dijk JH, Bolton C, Persaud D, Moss WJ: Eff  ectiveness of 
antiretroviral therapy among HIV-infected children in sub-Saharan Africa. 
Lancet Infect Dis 2008, 8(8):477-489.
3.  World Health Organization Mortality Data. 2006 [http://www.who.int/
whosis/mort/en/index.html]
4.  Towards Universal Access: Scaling up priority HIV/AIDS interventions in the health 
sector 2009. New York: World Health Organization; 2009.
5.  Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F: 
Mortality of infected and uninfected infants born to HIV-infected mothers 
in Africa: a pooled analysis. Lancet 2004, 364(9441):1236-1243.
6.  Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, 
McIntyre JA: Early antiretroviral therapy and mortality among HIV-infected 
infants. N Engl J Med 2008, 359(21):2233-2244.
7. Graff   Zivin J, Thirumurthy H, Goldstein M: AIDS treatment and intrahousehold 
resource allocation: Children’s nutrition and schooling in Kenya, NBER Working 
Papers 12689. National Bureau of Economic Research; 2006.
8.  Mermin J, Were W, Ekwaru JP, Moore D, Downing R, Behumbiize P, Lule JR, 
Coutinho A, Tappero J, Bunnell R: Mortality in HIV-infected Ugandan adults 
receiving antiretroviral treatment and survival of their HIV-uninfected 
children: a prospective cohort study. Lancet 2008, 371(9614):752-759.
9.  Thirumurthy H, Graff   Zivin J, Goldstein M: The economic impact of AIDS 
treatment: Labour supply in Western Kenya, Economic Growth Center 
Discussion Paper Number 947. New Haven, Conneticut: Yale University; 2006.
10.  Diabate S, Alary M, Koffi    CK: Determinants of adherence to highly active 
antiretroviral therapy among HIV-1-infected patients in Cote d’Ivoire. AIDS 
2007, 21(13):1799-1803.
11.  Merenstein D, Schneider MF, Cox C, Schwartz R, Weber K, Robison E, Gandhi 
M, Richardson J, Plankey MW: Association of child care burden and 
household composition with adherence to highly active antiretroviral 
therapy in the women’s interagency HIV study. AIDS Patient Care STDS 2009, 
23(4):289-296.
12.  Porricolo M, Abadi J, Rosenberg M, Dobroszycki J, Wiznia A: Family centered 
care: a sensitive, sensible, and simple approach to caring for HIV-infected 
children and families. In Proceedings of the XVI International AIDS Conference. 
Toronto, Canada; 2006.
13.  Williams PL, Van Dyke R, Eagle M, Smith D, Vincent C, Ciupak G, Oleske J, 
Seage GR, 3rd: Association of site-specifi  c and participant-specifi  c factors 
with retention of children in a long-term pediatric HIV cohort study. Am J 
Epidemiol 2008, 167(11):1375-1386.
14.  Shelton TL, Jeppson ES, Johnson BH: Family-centered care for children with 
special health needs. Washington, DC: Association for the Care of Children’s 
Health; 1987.
15. Tolle  MA:  A package of primary health care services for comprehensive 
family-centred HIV/AIDS care and treatment programs in low-income 
settings. Trop Med Int Health 2009, 14(6):663-672.
16.  Wakhweya A, Dirks R, Yeboah K: Children thrive in families: Family centered 
models of care and support for orphans and other vulnerable children aff  ected by 
HIV and AIDS. Joint Learning Initiative on Children and HIV/AIDS; 2008.
17.  El-Sadr WM, Rabkin M, Abrams EJ, Hoos D, Berkman A, Myer L, Hardy TW, 
Rosenfi  eld A: Successful enrollment of families with HIV disease in the 
MTCT-plus initiative. In Proceedings of the XV International AIDS Conference. 
Bangkok, Thailand; 2004.
18.  Abrams EJ, Kaytal M, Nash D, Toro P, Coakley E, El-Sadr W: Response to 
antiretroviral therapy in children enrolled in the Columbia MTCT-Plus 
Initiative. In Proceedings of the 3rd IAS Conference on HIV Pathogenesis and 
Treatment. Rio de Janeiro, Brazil; 2005.
19.  Abrams EJ, Myer L, Rosenfi  eld A, El-Sadr WM: Prevention of mother-to-child 
transmission services as a gateway to family-based human 
Table 2. Family-centred care “wish list”
HIV + TB care  Paediatric + adult primary care  Psychosocial/economic support  Administrative
•  PMTCT  •  Immunizations  •  Adherence counselling for adults  •  Follow up and patient tracking
•  VCT, including viral diagnostic   •  Growth monitoring    and children  •  A tight network of referrals and
  tests for early infant diagnosis  •  Routine neurodevelopmental  •  Psychosocial support for both HIV+     linkages with community-based
•  Opportunistic infection     assessments    and HIV- caregivers, including    organizations
  prophylaxis   •  Nutritional supplementation and    substance abuse, mental health, and  •  Monitoring and evaluation systems
•  HAART for adults and children    infant feeding support    domestic violence education 
•  Regular TB screening, INH   •  Reproductive health services, including  •  Psychosocial support for children:  
  prophylaxis, and treatment     cervical screening and STD care    social and educational activities 
    •  Family planning services   •  Early childhood development 
    •  Insecticide-treated bed nets, malaria     programmes
      screening and treatment   •  Subsidized patient transport to and
    •  Management of other endemic     from the clinic
      disease (e.g., helminths)  •  Income assistance
    •  Management of chronic illness:  
      cardiovascular disease, Type II  
      diabetes, hyperlipidemia  
    •  Safe drinking water 
    •  Pain management and palliative care 
    •  Home health visits for pregnant 
      mothers and young children
Tolle, Degennaro, DeBaets, and Richter [15,43,47,54]
Additional File 1. Family-centred care programme data (Word 
document).
Leeper et al. Journal of the International AIDS Society 2010, 13(Suppl 2):S3 
http://www.jiasociety.org/content/13/S2/S3
Page 9 of 11immunodefi  ciency virus care and treatment in resource-limited settings: 
rationale and international experiences. Am J Obstet Gynecol 2007, 
197(3 Suppl):S101-106.
20.  Sendzik D, Thompson K: HIV family-centered care: Supporting quality care 
for HIV-positive caregivers. In Proceedings of the XVI International AIDS 
Conference. Toronto, Canada; 2006.
21.  Sendzik D, Thompson K: Family-centered approach improves adherence to 
care. In Proceedings of the XVII International AIDS Conference. Mexico City, 
Mexico; 2008.
22.  Eley B, Nuttall J, Davies MA, Smith L, Cowburn C, Buys H, Hussey G: Initial 
experience of a public sector antiretroviral treatment programme for 
HIV-infected children and their infected parents. S Afr Med J 2004, 
94(8):643-646.
23.  Habibu Y, Gwarzo U, Ibrahim M, Keshinro B, Roos J, Stuart L: Integrated HIV 
care and treatment for children and parents through family-centered care 
at a secondary level hospital in Kano, Nigeria. Abstract no. CDB1220. In 
Proceedings of the XVI International AIDS Conference. Toronto, Canada; 2006.
24.  Lusiama J, Edmonds A, Kitetele F, Lelo P, Shabani N, Tshikandu T, Akele K, Van 
Rie A, Behets F: Famiy-centered approach to pediatric HIV treatment and 
care: experience at the Kalembe Lembe Pediatric Hospital, Kinshasa, 
Democratic Republic of the Congo. In Proceedings of the XVII International 
AIDS Conference. Mexico City, Mexico; 2008.
25.  Midturi J, Cox C, Kabue M, Kazembe P, Kline M: A Retrospective case-
controlled analysis of children enrolled in a family centered care clinic at 
Baylor College of Medicine—Abbot Fund Children’s Clinical Centre of 
Excellence (COE). In Proceedings of the XVII International AIDS Conference. 
Mexico City, Mexico; 2008.
26.  Reddi A, Leeper SC, Grobler AC, Geddes R, France KH, Dorse GL, Vlok WJ, 
Mntambo M, Thomas M, Nixon K, Holst HL, Karim QA, Rollins NC, Coovadia 
HM, Giddy J: Preliminary outcomes of a paediatric highly active 
antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC 
Pediatr 2007, 7:13.
27.  Tonwe-Gold B, Ekouevi DK, Bosse CA, Toure S, Kone M, Becquet R, Leroy V, 
Toro P, Dabis F, El Sadr WM, Abrams EJ: Implementing family-focused HIV 
care and treatment: the fi  rst 2 years’ experience of the mother-to-child 
transmission-plus program in Abidjan, Cote d’Ivoire. Trop Med Int Health 
2009, 14(2):204-212.
28.  van Griensven J, De Naeyer L, Uwera J, Asiimwe A, Gazille C, Reid T: Success 
with antiretroviral treatment for children in Kigali, Rwanda: experience 
with health center/nurse-based care. BMC Pediatr 2008, 8:39.
29.  Van Winghem J, Telfer B, Reid T, Ouko J, Mutunga A, Jama Z, Vakil S: 
Implementation of a comprehensive program including psycho-social 
and treatment literacy activities to improve adherence to HIV care and 
treatment for a pediatric population in Kenya. BMC Pediatr 2008, 8:52.
30.  Gibb DM, Masters J, Shingadia D, Trickett S, Klein N, Duggan C, Novelli V, 
Mercey D: A family clinic—optimising care for HIV infected children and 
their families. Arch Dis Child 1997, 77(6):478-482.
31.  Yalala S, Roger I, Kabamba J, Mavakala K, Tabala M, Sander P, N’ku D, Behets F: 
Family-centered HIV services at a primary health care center for women 
identifi  ed as HIV+ during antenatal care. In Proceedings of the XVII 
International AIDS Conference. Mexico City; 2008.
32.  Kabugo C, Buzaalirwa L, Okong P, Munduru B: Outcome of care in a MTCT-
PLUS model of care in Uganda. In Proceedings of the 4th IAS Conference on HIV 
Pathogenesis, Treatment and Prevention. Sydney, Australia; 2007.
33.  Marima R, Penner J, Bukusi E, Cohen C: Family-centered HIV services: a 
model to improve care. In Proceedings of the XVI International AIDS 
Conference. Toronto, Canada; 2006.
34.  Sheehy M, Scorgie F, Mini NP, Waimar T, Kellerman S: A family-centered 
approach increases HIV testing among family members of persons in care 
for HIV. In Proceedings of the 5th IAS Conference on HIV Pathogenesis, Treatment 
and Prevention. Cape Town, South Africa; 2009.
35.  van Kooten Niekerk NK, Knies MM, Howard J, Rabie H, Zeier M, van Rensburg 
A, Frans N, Schaaf HS, Fatti G, Little F, Cotton MF: The fi  rst 5 years of the 
family clinic for HIV at Tygerberg Hospital: family demographics, survival 
of children and early impact of antiretroviral therapy. J Trop Pediatr 2006, 
52(1):3-11.
36. Kiromera  A:  Family centered PMTCT and antiretroviral therapy in a poor 
rural setting in Malawi. In Proceedings of the XVI International AIDS Conference. 
Toronto, Canada; 2006.
37.  Byakika-Tusiime J, Crane J, Oyugi JH, Ragland K, Kawuma A, Musoke P, 
Bangsberg DR: Longitudinal antiretroviral adherence in HIV+ Ugandan 
parents and their children initiating HAART in the MTCT-Plus family 
treatment model: role of depression in declining adherence over time. 
AIDS Behav 2009, 13(Suppl 1):82-91.
38.  Fielder JF, Kwatampora L: Staged introduction of antiretroviral therapy into 
a family with multiple HIV-infected members. J Int Assoc Physicians AIDS 
Care (Chic Ill) 2009, 8(1):68-72.
39.  Callaway CC, Brady MT, Crim LB, Hunkler JA: Family-centered care provides 
women with a one-stop shopping approach. In Proceedings of the National 
Conference on Women & HIV. Los Angeles, California; 1997.
40.  Medley A, Garcia-Moreno C, McGill S, Maman S: Rates, barriers and 
outcomes of HIV serostatus disclosure among women in developing 
countries: implications for prevention of mother-to-child transmission 
programmes. Bull World Health Organ 2004, 82(4):299-307.
41.  Africa’s Orphaned and Vulnerable Generations: Children Aff  ected by AIDS. 
New York: UNICEF; 2006.
42.  Mudzingwa S, Sengayi M, Bwakura-Dangarembizi M, Nathoo KJ, 
Mandidewa R, Dzapazi R, Marozva C, Katananda C, Nyoni D, Chipiti M, 
Muchabaiwa D, Maturure J, Mapinge F, Kibenge R, Musinguzi Bwango M, 
Aello J, Naidoo B: HIV-status and healthcare needs of primary caregivers of 
HIV-infected children in the ARROW trial in Zimbabwe. In Proceedings of the 
5th IAS Conference on HIV Pathogenesis, Treatment and Treatment. Cape Town, 
South Africa; 2009.
43.  DeGennaro V, Zeitz P: Embracing a family-centred response to the HIV/
AIDS epidemic for the elimination of pediatric AIDS. Glob Public Health 
2009, 4(4):386-401.
44. DeGennaro  V:  Survey of service delivery organizations reveals current state 
of pediatric HIV/AIDS and the failure to treat children. In Proceedings of the 
15th Annual Global Health Education Consortium Conference. Toronto, Canada; 
2006.
45.  Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, Chintu N, Stringer EM, Chi 
BH, Sinkala M, Kankasa C, Wilson CM, Wilfert CM, Mwango A, Levy J, Abrams 
EJ, Bulterys M, Stringer JS: Clinical outcomes and CD4 cell response in 
children receiving antiretroviral therapy at primary health care facilities in 
Zambia. JAMA 2007, 298(16):1888-1899.
46.  Meyers T, Moultrie H, Naidoo K, Cotton M, Eley B, Sherman G: Challenges to 
pediatric HIV care and treatment in South Africa. J Infect Dis 2007, 
196(Suppl 3):S474-481.
47.  De Baets AJ, Bulterys M, Abrams EJ, Kankassa C, Pazvakavambwa IE: Care and 
treatment of HIV-infected children in Africa: issues and challenges at the 
district hospital level. Pediatr Infect Dis J 2007, 26(2):163-173.
48.  Kline MW, Ferris MG, Jones DC, Calles NR, Mizwa MB, Schwarzwald HL, 
Wanless RS, Schutze GE: The Pediatric AIDS Corps: responding to the 
African HIV/AIDS health professional resource crisis. Pediatrics 2009, 
123(1):134-136.
49.  Bahwere P, Piwoz E, Joshua MC, Sadler K, Grobler-Tanner CH, Guerrero S, 
Collins S: Uptake of HIV testing and outcomes within a Community-based 
Therapeutic Care (CTC) programme to treat severe acute malnutrition in 
Malawi: a descriptive study. BMC Infect Dis 2008, 8:106.
50.  Kankasa C, Carter RJ, Briggs N, Bulterys M, Chama E, Cooper ER, Costa C, 
Spielman E, Katepa-Bwalya M, M’Soka T, Ou CY, Abrams EJ: Routine off  ering 
of HIV testing to hospitalized pediatric patients at university teaching 
hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune 
Defi  c Syndr 2009, 51(2):202-208.
51.  Mehta SD, Hall J, Lyss SB, Skolnik PR, Pealer LN, Kharasch S: Adult and 
pediatric emergency department sexually transmitted disease and HIV 
screening: programmatic overview and outcomes. Acad Emerg Med 2007, 
14(3):250-258.
52.  Rollins N, Mzolo S, Moodley T, Esterhuizen T, van Rooyen H: Universal HIV 
testing of infants at immunization clinics: an acceptable and feasible 
approach for early infant diagnosis in high HIV prevalence settings. AIDS 
2009, 23(14):1851-1857.
53.  Kiragu K, Schenk K, Murugi J, Sarna A: ‘If you build it, will they come?’ Kenya 
healthy start pediatric HIV study: A diagnostic study investigating barriers to HIV 
treatment and care among children, Horizons Final Report. Washington, DC: 
The Population Council, Inc.; 2008.
54.  Richter L, Sherr L, Adato M, Belsey M, Chandan U, Desmond C, Drimie S, 
Haour-Knipe M, Hosegood V, Kimou J et al: Strengthening families to 
support children aff  ected by HIV and AIDS. AIDS Care 2009, 21:3-12.
55. Belsey  M:  AIDS and the family: policy options for a crisis in family capital. New 
York: United Nations, Department of Economic and Social Aff  airs; 2005.
56.  Himid KA, Zwi K, Welch JM, Ball CS: The development of a community-
Leeper et al. Journal of the International AIDS Society 2010, 13(Suppl 2):S3 
http://www.jiasociety.org/content/13/S2/S3
Page 10 of 11based family HIV service. AIDS Care 1998, 10(2):231-236.
57.  Ida J, Turnbull I, Lao L, Desai N: Evolving from pediatric centered to family 
centered HIV care: policy pressures due to a changing epidemic. In 
Proceedings of the XVI International AIDS Conference. Toronto, Canada; 2006.
58.  Okubamichael EA, Ntumy R, Hairston AF, Mote M, Costa C, Abrams E: 
Integrating PMTCT of HIV and HIV/AIDS care and treatment services in 
antenatal clinics: Maseru, Lesotho. In Proceedings of the Fourth Annual HIV/
AIDS Implementers’ Meeting. Kigali, Rwanda; 2007.
59.  Wamalume C, Stringer EM, Luhanga D, Makuka I, Goldenberg RL, Simwanza 
M, Levy J, Stringer JS, Sinkala M: Care and treatment of HIV infected families 
is feasible in Lusaka, Zambia. In Proceedings of the XV International AIDS 
Conference. Bangkok; 2004.
doi:10.1186/1758-2652-13-S2-S3
Cite this article as: Leeper SC, et al.: Lessons learned from family-centred 
models of treatment for children living with HIV: current approaches and 
future directions. Journal of the International AIDS Society 2010, 13(Suppl 2):S3.
Leeper et al. Journal of the International AIDS Society 2010, 13(Suppl 2):S3 
http://www.jiasociety.org/content/13/S2/S3
Page 11 of 11